P P- P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 PA PB PC PD PE PF PG PH PI PK PL PM PN PO PP PQ PR PS PT PU PV PW PX PY
Palivizumab
[A humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylaxis application of Respiratory Syncytial Virus infections. RSV F protein, a small envelop glycoprotein, not only is required for cytopathic syncytia resulted from cell-to-cell fusion, but also is necessary for viral spreading and evading neutralizing antibody. Palivizumab neutralizes and inhibit fusion activity of RSV, thereby prevent the syncytia formation. Administration of this antibody does not interfere with other immunization. ( NCI )]
UMLS (NCI) C0672596- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor
Relation/PAR: [AM800] ANTIVIRALS
Unclassified Ingredients
Unclassified Ingredients
Relation/CHD: PALIVIZUMAB 50 MG
PALIVIZUMAB 100 MG
PALIVIZUMAB 100 MG
Buy website
Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.Affordable prices from $100.
  |
home
